ModelEdge
Scinai Immunotherapeutics Ltd
SCNI
Filing type
20-F
Filing date
May 14, 2024
Updated
May 15, 2024 ยท 2:01 PM

Filing

20-FAnnual and Transition Report of Foreign Private Issuers

Exhibits

EX-2.3DESCRIPTION OF SHARE CAPITALEX-12.1CERTIFICATIONEX-12.2CERTIFICATIONEX-13.1CERTIFICATIONEX-13.2CERTIFICATIONEX-15.1CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANTEX-15.2CONSENT OF KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE REGISTRANTEX-16.1LETTER, FROM KOST FORER GABBAY & KASIERER, CERTIFIED PUBLIC ACCOUNTANT (ISR.), A MEMBER OF ERNST & YOUNG GLOBAL, TO THE SECURITIES AND EXCHANGE COMMISSION, DATED, MAY 15, 2024EX-97.1SCINAI IMMUNOTHERAPEUTICS POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATIONGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic